1. The "Blind Injection" Problem
A trend has taken hold in the biohacking community: researchers picking a peptide because it worked for someone online, then running it with zero baseline data. No panel before, no panel during. This is not optimization — it's guessing with a needle. The body doesn't respond to what's trending; it responds to its own internal chemistry, and that chemistry is only visible through blood work.
The clearest way to understand why "more peptide" doesn't always mean "more result" is what we call the Construction Site Framework. Growth hormone is the foreman calling the crew to work. IGF-1 is the crew actually carrying the bricks. If you send more workers to a site that's already fully staffed, the job doesn't finish faster — the workers trip over each other, and you get a safety hazard instead of a building. Every biomarker in this guide answers one question: is the site actually short-staffed, or already full?
How to use this guide: Each system below maps its biomarkers to the research peptides it's most relevant to. Pull a comprehensive panel before starting any protocol, and re-test on the cadence in Section 7.
2. Five Systems, Fifteen Markers
Growth Hormone Axis
IGF-1 · Insulin · HbA1c · AST/ALT · Free T3 · Cortisol
IGF-1 is the liver's downstream signal of GH activity. Introducing a secretagogue when IGF-1 is already mid-range doesn't accelerate anything — it pushes toward joint stress, non-target tissue proliferation, and cardiovascular strain. Insulin resistance and liver stress independently blunt whatever IGF-1 the body can produce; low Free T3 turns a Tesamorelin-driven appetite spike into fat gain instead of lean tissue; elevated cortisol directly antagonizes GH.
Relevant to: Tesamorelin · CJC-1295 · Ipamorelin · GHRP-6
Hormonal Recovery
Testosterone · Estradiol · LH/FSH · SHBG · Hematocrit
Decades of synthetic estrogen in water supplies plus more recent plastic-derived xenoestrogens have shifted an entire generation's hormonal baseline. This is usually a signaling failure between pituitary and testes, not a production failure — if LH is low while estradiol is high, the testes are likely intact but not being told to work. That's the case Enclomiphene addresses, without the fertility trade-offs of exogenous TRT.
Relevant to: Enclomiphene · Kisspeptin · HCG
Fat Loss & Cardiovascular Risk
ApoB · Fasting Glucose
Standard cholesterol panels measure the total weight of lipids in circulation — but weight isn't what causes arterial plaque, particle count is. ApoB counts the atherogenic particles directly, which makes it a far sharper cardiovascular predictor than LDL-C alone during protocols that shift lipid metabolism rapidly. Fasting glucose is a useful proxy for mitochondrial efficiency, specifically relevant to MOTS-c's mechanism.
Relevant to: Retatrutide · Semaglutide · Tirzepatide · MOTS-c
Inflammation & Cognitive
hs-CRP · Homocysteine
hs-CRP is arguably the single most important marker on this list — it determines whether any peptide can reach its target tissue at all. Systemic inflammation creates a pharmacokinetic barrier that causes protocols to fail on inflammatory load alone, independent of peptide quality. For cognitive protocols, elevated homocysteine plays a similar gatekeeper role — B12 and folate are the standard first-line correction before layering in Semax, Selank, or Pinealon.
Relevant to: BPC-157 · TB-500 · Semax · Selank · Pinealon
Aesthetic: Hair, Skin & Copper
Ferritin · Vitamin D · Copper
GHK-Cu is a signaling molecule, not a raw material — it tells cells to produce collagen and support follicle health but can't manufacture the building blocks itself. Ferritin and Vitamin D deficiency are the two most common drivers of hair thinning; low serum copper means the protocol is structurally incomplete regardless of dose.
Relevant to: GHK-Cu
3. Reference Ranges at a Glance
| Marker | Low / Deficit | Research Target | High-Risk Zone |
|---|---|---|---|
| IGF-1 | < 100 ng/mL | 120–250 ng/mL | > 300 ng/mL |
| Fasting Insulin | — | 3–6 µIU/mL (< 8) | > 10 µIU/mL |
| HbA1c | — | < 5.4% | > 5.7% |
| AST / ALT | — | 10–40 U/L (< 30 ideal) | > 40 U/L |
| Free T3 | < 3.2 pg/mL | 3.2–4.5 pg/mL | — |
| Morning Cortisol | < 10 | 10–18 | > 18 |
| Total Testosterone | — | 700–1200+ ng/dL | — |
| SHBG | — | < 40 nmol/L | > 40 nmol/L |
| Hematocrit | — | < 52% | > 52% |
| ApoB | — | < 70–80 mg/dL | > 80 mg/dL |
| hs-CRP | — | < 0.5 mg/dL | > 1.0 mg/dL |
| Homocysteine | — | Low end of range | Above lab range |
Hematocrit safety threshold: Testosterone-adjacent protocols increase red blood cell mass. Above 52%, blood viscosity rises meaningfully — the standard mitigation is a therapeutic blood donation, which functions like an oil change for blood volume.
4. Suggested Testing Cadence
Before any protocol
Baseline Panel
Full panel — IGF-1, ApoB, hs-CRP, Testosterone Trifecta (Total T, LH/FSH, SHBG, Estradiol), Morning Cortisol, Fasting Insulin/Glucose, HbA1c, AST/ALT, Hematocrit.
Weeks 4–6
Signaling Protocols
Re-test relevant axis markers when running Enclomiphene or other signaling-restoration peptides to confirm the pituitary–gonadal connection is re-establishing.
Quarterly
Maintenance
HbA1c, Fasting Insulin, Hematocrit — the three markers most likely to drift silently during an ongoing protocol.
Annually
Deep Panel
Homocysteine, Ferritin, Vitamin D, Copper — slower-moving markers that still gate the aesthetic and cognitive categories.
Already have your numbers?
Map your protocol to the calculator.
Once your panel tells you which compound class is actually indicated, use the reconstitution and dosage calculator to plan the practical side — concentration, syringe units, and doses per vial.
Open Calculator →
5. FAQ
What blood tests should I get before starting a peptide protocol?
A comprehensive baseline panel covers five systems: IGF-1, fasting insulin, HbA1c, liver enzymes, Free T3 and morning cortisol for the growth hormone axis; total testosterone, estradiol, LH/FSH, SHBG and hematocrit for hormonal recovery; ApoB and fasting glucose for cardiovascular/fat-loss protocols; hs-CRP and homocysteine for inflammation and cognitive protocols; and ferritin, vitamin D and copper for aesthetic protocols like GHK-Cu.
Why does hs-CRP matter so much for peptide research?
High-sensitivity CRP measures systemic inflammation, which creates a pharmacokinetic barrier — peptides circulating in a high-inflammation environment struggle to reach target tissue. A protocol can fail purely on inflammatory load, independent of peptide quality or dose, which is why hs-CRP under 0.5 mg/dL is the target before running BPC-157, TB-500, or most other research peptides.
How often should biomarkers be re-tested during a protocol?
Baseline testing happens before any protocol starts. Signaling-restoration compounds like Enclomiphene warrant re-testing at 4-6 weeks. Fast-moving markers (HbA1c, fasting insulin, hematocrit) should be checked quarterly during maintenance. Slower-moving markers (homocysteine, ferritin, vitamin D, copper) are typically an annual check.
Can biomarkers explain why a peptide protocol isn't working?
Yes — a non-responder is rarely a mystery once the right panel is run. Elevated hs-CRP blocks peptide transport, elevated SHBG limits bioavailable testosterone despite normal total testosterone, and elevated Reverse T3 signals the body deliberately suppressing metabolic rate. These are the most common lab-detectable reasons a protocol underperforms.
6. Closing Remarks
None of the reference ranges above replace a licensed physician reading your actual chart in context — individual history, medication interactions, and comorbidities all change how a number should be interpreted. What this guide replaces is guessing. A researcher who pulls a comprehensive panel before selecting a compound is working from data; a researcher who isn't, is running an uncontrolled experiment on themselves.
For the physiology behind individual compounds, see our Research Library. For full profiles including dosage references, browse the Encyclopedia.
⚠ Research Use Only Disclaimer: All content in this article and all products sold by BioPeptidyne are strictly for research use only (RUO) and are not intended for human consumption, diagnostic use, or therapeutic application. Nothing in this article constitutes medical advice. Reference ranges are for research context only — always consult a licensed physician and use an accredited diagnostic laboratory before interpreting any biomarker or initiating any protocol.